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Abstract
Nearly 15 years after the first description of neutrophil extra-
cellular traps (NETs), our knowledge concerning this struc-
ture has expanded considerably. Initially, NETs were consid-
ered solely an elaborate function of the innate immune 
system to combat invading microorganisms. Successively it 
became clear that NETs have farther-reaching capabilities. 
They are involved in a series of pathophysiological mecha-
nisms ranging from inflammation to thrombosis where they 
fulfill essential functions when produced at the right site and 
the right time but can have a serious impact when genera-
tion or clearance of NETs is inadequately controlled. This re-
view provides a concise overview on the far-reaching func-
tions of NETs in health and disease. © 2018 S. Karger AG, Basel
Structure and Generation of Neutrophil Extracellular 
Traps
In 2004, a paper was published describing that human 
neutrophils, when treated with the mitogen phorbol my-
ristate acetate (PMA), undergo a characteristic form of 
cell death that is neither necrosis nor apoptosis [1]. A re-
port on the response of neutrophils treated with PMA had 
already been published by a Japanese group in 1996 [2]. 
At that time, it was not apparent that this form of cell 
death results in the formation of large 3-D structures 
composed of thin chromatin fibers studded with granular 
and cytoplasmic proteins and peptides. The main protein 
components of neutrophil extracellular traps (NETs) are 
histones, followed by granular enzymes and peptides 
including neutrophil elastase (NE), myeloperoxidase 
(MPO), cathepsin G, leukocyte proteinase 3 (PR3), lacto-
ferrin, gelatinase, lysozyme C, calprotectin, neutrophil 
defensins, and cathelicidins [3]. These structures were 
named NETs, and the peculiar cell death pathway was 
termed NETosis, accordingly [4]. A large number of in-
ducers of NETosis have been described, including bacte-
ria or bacterial components [1], fungi [5], protozoa [6, 7], 
viruses [8], activated platelets [9], complement-derived 
peptides [10], autoantibodies [11], IL-8 [1], hydrogen 
peroxide [12], urate crystals [13], cigarette smoke [14], 
and ionophores [15]. PMA-induced NETosis has been 
studied in some detail and a number of molecular events 
leading to NET formation have been identified. PMA di-
rectly binds to protein kinase C, calcium is released from 
intracellular stores, and the Raf-MEK-ERK pathway is ac-
tivated [16]. Further downstream, the multimeric com-
plex of NADPH oxidase assembles at the phagosomal 
membrane and generates reactive oxygen species [12]. 
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Patients with chronic granulomatous disease suffer from 
recurrent infections due to an inactive NADPH oxidase 
complex. Restoration of its function by gene therapy re-
establishes the ability to form NETs and to overcome fun-
gal lung infections [17]. The granular serine protease NE 
is mobilized together with MPO and it is transported to 
the nucleus where it processes core histones [18, 19]. The 
rise in intracellular calcium levels activates also peptidyl-
arginine deiminase 4, which converts arginines in his-
tones to citrullines, resulting in a reduction of the positive 
charge of these proteins [20–22]. Together, these molecu-
lar events decrease the compaction of chromatin. Conse-
quently, after about 2 h, PMA-stimulated neutrophils lose 
heterochromatic areas of the nucleus as well as the char-
acteristic nuclear lobuli. As a result, nuclei round up and 
expand. The nuclear envelope disintegrates into vesicles, 
granules, and mitochondria break down. Cytoplasm and 
karyoplasm intermingle and finally the cell membrane 
ruptures and releases the cellular content, which unfolds 
in the extracellular space to form NETs [12]. 
Physiological induction of NETosis is dependent on 
receptors including integrins and Toll-like receptors [7, 
23], but it can also be induced by ionophores like A23187 
and nigericin. In this case, activation of protein kinase C 
is not required [24]. Independently of the stimulus, NET 
formation does not require transcription [25]. The break-
down of the nuclear envelope is reminiscent of mitosis, 
and NETosis is strongly induced by PMA, which also acts 
as a mitogen. Two other mitogens, the plant lectins con-
canavalin A and phytohemagglutinin, also induce NET 
formation. In contrast to unstimulated cells, neutrophils 
treated with these mitogens express the cell division 
marker Ki-67 in their nuclei [26]. Furthermore, cyclin-
dependent kinase (CDK) 6 transiently enters the nucleus 
after PMA stimulation. CDK6 inhibition blocks NET for-
mation, and neutrophils from a CDK6–/– mouse strain 
are impaired in NET production. In summary, the path-
ways for NETosis and mitosis share some components, 
although the outcome is different.
This series of events is called suicidal NETosis. In con-
trast, it has been reported that neutrophils can release part 
of or the entire nucleus without breaching the cell mem-
brane, resulting in anuclear cytoplasts that are still able to 
move and phagocytose bacteria [27]. When coculturing 
neutrophils with Staphylococcus aureus, a very rapid re-
lease of DNA was monitored [28]. Nuclei underwent mas-
sive dilation of the nuclear envelope and vesicle formation. 
These vesicles contained DNA and finally fused with the 
cell membrane, releasing their contents without cell lysis. 
Similar neutrophil behavior was described using intravital 
imaging and was found to be dependent on TLR2 and C3 
[23]. The neutrophils remained viable even after the release 
of nuclear DNA and continued to move inside the tissue 
although their crawling pattern differed from that of neu-
trophils containing nuclei. Since neutrophils survive this 
form of discharging DNA, it is called vital NETosis.
It has been proposed that upon GM-CSF priming and 
subsequent stimulation with LPS or complement factor 5a 
neutrophils release mitochondrial but not nuclear DNA 
[10]. In the extracellular space, DNA binds to granular en-
zymes like NE or MPO. The resulting structures differ con-
siderably from NETs since their main protein component, 
i.e., histones, is missing. Furthermore, no mechanism for 
the release of mitochondrial DNA has been proposed, and 
so far it is unclear whether the minor DNA content of mi-
tochondria would suffice for the large amount of DNA-
containing structures that have been detected. 
NET formation is evolutionarily conserved within the 
kingdoms of animals and plants and has been described 
in different mammalian species [1, 6, 29–31], birds [32], 
fish [31, 33], invertebrates [34, 35], and plants that protect 
their root tips against fungal infections with extracellular 
DNA [36].
Antimicrobial Activity of NETs
NETs bind gram-positive as well as gram-negative 
bacteria (Fig. 1). Their antimicrobial activity is direct by 
killing the pathogens but also indirect by preventing fur-
ther spread from the entry point. NETs are 3-D structures 
composed of the following toxic components: DNA [37], 
histones [38, 39], granular enzymes like NE, MPO, ca-
thepsin G, and antimicrobial peptides like defensins and 
cathelicidins. Negatively charged DNA serves as a back-
bone. When this is degraded by DNases, the structural 
integrity of NETs is impaired [1]. Consequently, bacte-
rial strains that express DNases can be more pathogenic 
than DNase-negative strains, and conversely the de novo 
expression of DNases by otherwise harmless bacteria 
renders them more virulent [40–42].
S. aureus has found a way to degrade NETs and estab-
lish a sheltered niche [43]. By converting NETs to deoxy-
adenosine, S. aureus not only escapes killing by NETs 
but also avoids phagocytosis, creating abscesses that are 
devoid of macrophages since they respond to deoxy-
adenosine by apoptosis.
NETs are also active against fungi, e.g., they can kill 
both yeast and hyphal forms of Candida albicans [5]. In-
terestingly, neutrophils can sense the size of pathogens 
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and produce more NETs when in contact with hyphae 
compared to yeast [44]. 
When analyzing the fate of different C. albicans strains 
in lung infections, the same group found that yeast-locked 
fungi were controlled by a relatively low number of 
phagocytosing neutrophils, while WT strains that form 
hyphae in the lung were attacked by large numbers of 
neutrophils forming clusters around the hyphae. IL-1β 
signaling was critical for the massive recruitment of neu-
trophils to hyphae, while it played no role for the neutro-
phils phagocytosing yeast forms [45].
Pathogenic Potential
NETs are structures with a high local concentration of 
very active molecules. The strong intermolecular binding 
prevents individual components from diffusing into 
neighboring tissue, thus limiting tissue damage. If the 
amount and the site of NET formation, as well as their 
timely removal, are not tightly controlled, the presence of 
NETs can have serious consequences and it is linked to 
numerous pathophysiological processes, some of which 
are presented here.
Cardiovascular Diseases
Although the pathogeneses of atherothrombosis and 
venous thrombosis are very different, NET formation is 
involved in both. Often induced by hypoxia due to a re-
duced blood flow, venous endothelium is activated, re-
leases von Willebrand factor, and upregulates P-selectin. 
Platelets and neutrophils are recruited. Activated plate-
lets can induce neutrophils to release NETs, which serve 
as a scaffold for further platelets. Erythrocytes bind to the 
developing thrombus and stabilize it. DNase treatment 
dissolves the thrombus as does heparin [46], a potent an-
ticoagulant with a high affinity for histones which dis-
places histones from chromatin [47].
In a flow restriction model of deep vein thrombosis it 
was found that neutropenic mice develop no or signifi-
cantly smaller thrombi compared to control mice [48]. In 
areas of restricted blood flow, neutrophils release large 
amounts of NETs, which form a dense network with fi-
brin and platelets. Treatment with DNase dismantled 
NETs, resulting in significantly smaller thrombi, as did 
administration of heparin.
A Link between NETs, Thrombosis, and Innate 
Immunity
It was proposed that thrombosis could be considered 
a means of the immune system to promote immune de-
fense [49]. By inducing microthrombi in microvessels 
during infection with blood-borne pathogens, bacteria 
are killed by NET components or further dissemination 
into neighboring tissue is limited. Since thrombosis un-
der these conditions is restricted to a small percentage of 
microvessels, e.g. of the liver, the overall function of the 
respective organ is not at risk.
Atherothrombosis starts with dysfunctional endothe-
lium. It has been shown that NETs can be toxic to endo-
thelial cells [50]. Activated endothelium induces NET 
formation [51], which can create a vicious cycle resulting 
in more damage. Injured endothelium can lead to athero-
sclerosis, which is characterized by the accumulation of 
lipoproteins and monocytes in the subendothelial layer. 
Monocytes differentiate to macrophages that ingest large 
amounts of lipoprotein and cholesterol, which gives them 
a “foamy” appearance due to the numerous cytoplasmic 
vesicles. Gradually, a plaque builds up that increasingly 
obstructs the blood flow. Rupture of the plaque leads to 
immediate blood clotting, which can result in complete 
artery closure inducing hypoxia and tissue damage in 
downstream organs.
Warnatsch et al. [52] found that NETs play a signifi-
cant role in the progression to plaque formation. When 
human neutrophils come in contact with cholesterol 
crystals, they spontaneously undergo NETosis [52]. They 
Fig. 1. Scanning electron micrograph of purified human neutro-
phils that have produced NETs after cocultivation with P. aerugi-
nosa for 3 h. Scale bar, 1 µm.
NETs in the Second Decade 417J Innate Immun 2018;10:414–421
DOI: 10.1159/000489829
used a mouse model of atherosclerosis characterized by 
hypercholesterolemia and plaque formation and crossed 
this strain with mice that were deficient both in NE and 
PR3 and thus unable to produce NETs. These triple mu-
tant mice developed significantly fewer atherosclerotic 
lesions than did the parental hypercholesterolemic strain, 
which showed a similar reduction in lesion size when 
treated with DNase. Furthermore, it could be shown that 
in this setting NETs activate macrophages to produce 
proinflammatory cytokines.
The role of NETs in thrombosis was analyzed in a fer-
ric chloride artery injury model [53]. In mice deficient in 
NE and cathepsin G, fibrin deposition was markedly re-
duced 15 min after vessel injury compared to WT ani-
mals. This resulted in a reduced thrombus size and a lon-
ger time to-occlusion of the carotid artery and a pro-
longed tail-bleeding time. It could be shown that while 
thrombus-associated tissue factor pathway inhibitor 
(TFPI) is markedly degraded in WT mice, while most of 
the TFPI in thrombi of NE/CatG-deficient mice is non-
cleaved.
A noncanonical pathway to vascular occlusion has re-
cently been demonstrated [54]. It is assumed that NETs 
have a rather short lifetime in circulation due to the pres-
ence of serum DNases. As will be discussed later, patients 
with defects in DNase 1 develop autoantibodies against 
NET components due to the increased exposure of auto-
antigens in NETs that cannot be dismantled in a timely 
manner. Mice that not only lack the expression of DNase 
1 but are also deficient in DNase 1-like protein 3 (DNas1l3) 
are apparently normal. Surprisingly, during septicemia or 
sterile neutrophilia, they produce large amounts of NETs 
that cannot be degraded and rapidly lead to massive in-
travascular clot formation inducing organ damage and 
death. This clearly demonstrates the need of serum-ex-
pressed DNases for a timely removal of NETs.
Autoimmune and Autoinflammatory Diseases
Systemic lupus erythematosus (SLE) is characterized 
by the overproduction of autoantibodies against nuclear 
antigens like DNA and histones, but also against neutro-
phil granule proteins. Several studies have found that a 
subpopulation of systemic lupus erythematosus patients 
have a limited capacity to degrade NETs, and that this is 
associated with clinical manifestations [55, 56]. In these 
patients, NETs could not be degraded because they were 
shielded by autoantibodies against degradation by DNase 
1 or because inhibitors of DNase 1 were present in the 
sera. This correlation between the incomplete removal of 
NETs and phases of more severe disease could also ex-
plain why infections in these patients initiate flares.
In ANCA-associated small vessel vasculitis, an autoin-
flammatory disorder leading to necrotic inflammation of 
small blood vessels, autoantibodies are generated against 
2 neutrophil granular proteins, i.e., PR3 and MPO. Puri-
fied antibodies isolated from small vessel vasculitis pa-
tients and a mouse monoclonal against PR3 induced 
NET formation in TNF-α-primed neutrophils, in con-
trast to antibodies from healthy donors [11]. NETs were 
also found in kidney biopsies of small vessel vasculitis pa-
tients. In the absence of microbial infection, antibodies 
against granular NET components can induce a vicious 
cycle, which continuously provides more NETs. In a dif-
ferent study, it was shown that IgG from patients with 
microscopic polyangiitis readily induce NETs and that 
the amount of NET formation correlates with disease se-
verity [57]. NET induction by IgG purified from patients’ 
sera could be reduced by the addition of recombinant hu-
man MPO, indicating that autoantibodies were directed 
against this enzyme. In general, the NET-degrading ca-
pacity of microscopic polyangiitis sera was significantly 
reduced compared to that of sera from normal donors, 
further exposing autoantigens. 
Rheumatoid arthritis is a chronic autoinflammatory 
disorder mainly of the joints. Neutrophils are abundant 
in synovial fluids, especially during flares. Since most of 
the rheumatoid arthritis autoantibodies are directed 
against citrullinated proteins, NETs and their citrullinat-
ed components could be involved in induction of autore-
active B cells. Compared to neutrophils from healthy do-
nors, enhanced NETosis was observed in neutrophils 
from rheumatoid arthritis patients, both isolated from 
circulation and isolated from synovial fluid [58].
Synovial fluids contain large amounts of DNA, partly 
derived from NETs that contain peptidylarginine deimi-
nases 2 and 4. Both enzymes were also found freely dif-
fused in the fluid [59]. Release of the enzymes by neutro-
phils undergoing NETosis could explain the generation 
of citrullinated autoantigens. 
An anti-inflammatory function of NETs was proposed 
for gout. This is a form of inflammatory arthritis caused 
by high levels of uric acid, which can even crystallize as 
monosodium urate in the joints and induce severe pain, 
which lasts for hours or days. Monosodium urate crystals 
can form large aggregates called tophi, which contain nu-
merous neutrophils and large aggregates of NETs. Similar 
structures are formed in vitro when neutrophils are seed-
ed at a high density and treated with monosodium urate 
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crystals [60]. Probably due to the activity of enzymes as-
sociated to NETs, aggregates of these DNA structures 
were found to decrease the concentration of proinflam-
matory cytokines like IL-1β and TNF, which could ex-
plain the spontaneous termination of the inflammatory 
response typical of gout.
Fertility
During insemination of mares, numerous neutrophils 
are recruited to the fertilization tract in order to eliminate 
invading microorganisms. Interestingly, stallions with 
limited fertility lack a DNase-like protein in their seminal 
plasma. This correlation could be explained when it was 
found that bacteria in the fertilization tract were con-
stricted by NETs which also bound spermatozoa. These 
could only be released from NET trapping when DNase 
was present in seminal plasma [29]. 
Preeclampsia is a human pregnancy disorder charac-
terized by proteinuria and a sudden rise in blood pres-
sure, which occurs in about 2–8% of pregnancies. One 
hallmark of the disease is shedding of microparticles from 
the placental syncytiotrophoblast, which was shown to 
directly induce NETs in vitro [61]. The amount of NETs 
found in the intervillous space of the placenta was far 
higher in preeclampsia than in normal tissue, restricting 
blood flow and possibly increasing hypoxia [62].
Lung Diseases
Due to mutations in both copies of the gene for the cys-
tic fibrosis (CF) transmembrane conductance regulator, 
patients with CF suffer from accumulations of highly vis-
cous mucus in the lung, which clog the airways. Lung in-
fections with S. aureus, Haemophilus influenzae, and 
Pseudomonas aeruginosa are common and induce mas-
sive neutrophil infiltration and chronic inflammation. CF 
mucus contains large amounts of DNA, and most of the 
mucus DNA is complexed in NETs [63]. The amount of 
extracellular DNA directly correlates to poor pulmonary 
function [64]. CF symptoms can be treated by inhalation 
of recombinant DNase 1, which reduces the viscosity of 
a b
c
Fig. 2. Paraffin section of a C. albicans– 
infected mouse lung stained for neutrophil 
elastase (a, green in c) and histone 2B (b, 
red in c). The depicted area is rich in neu-
trophils that have partly formed NETs 
(arrows). The image is a 3-D reconstruc-
tion of a confocal stack. The side length of 
the squares in the background is 10.66 µm.
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CF mucus and improves lung function, but carries the risk 
of liberating highly active enzymes and toxic molecules 
like histones, which can damage the lung epithelium.
Chronic obstructive pulmonary disease (COPD) is 
also a persistent neutrophilic inflammation. After long-
term exposure to inhaled irritants like tobacco smoke, 
COPD patients suffer from recurrent bacterial and viral 
infections leading to repeated exacerbations. Tobacco 
smoke has been found to directly induce NET formation 
[14], possibly due to its LPS content. Additionally, nico-
tine directly induces NETosis [65–67], and it is not sur-
prising that NETs have been found in COPD lungs [68]. 
As is the case in CF, also in COPD disease severity cor-
relates to the amount of NETs, which is highest in phases 
of exacerbations [65]. 
NETs and Cancer
For a long time, neutrophils have been considered in-
ert bystander cells in cancer formation and metastasis, 
but this concept has changed, as reviewed recently [69]. 
In a small study with Ewing sarcoma patients, in 25% of 
cases NETs were found inside the tumor, and these pa-
tients developed metastases, indicating that NETs may 
promote tumor progression [70]. In a study comparing 
metastatic and nonmetastatic murine breast cancer cell 
lines it was found that more neutrophils were recruited to 
sites of implanted metastatic cells where they induced 
NET formation, while NETs were not found adjacent to 
implantation sites of nonmetastatic cells [71]. Further 
down the metastatic cascade, NETs have been shown to 
trap circulating tumor cells both in vitro and in vivo, lead-
ing to massive formation of micrometastases in the liver 
[72]. Interestingly, administration of DNase 1 or an in-
hibitor of NE reduced the metastatic burden to control 
levels. Although NETs have not been presented directly, 
in a cohort of patients with advanced cancer elevated lev-
els of citrullinated histone 3 (H3Cit) were found, which 
was not the case in age-matched individuals [73]. H3Cit 
could serve as a prognostic marker since in the analyzed 
cohort high levels of serum H3Cit strongly correlated 
with a poor clinical outcome.
Conclusion
In recent years, the interest in NETs has shifted from 
innate immune defense to their involvement in a multi-
tude of diseases ranging from infertility to cancer. It has 
become clear that uncontrolled NET formation or their 
insufficient removal can have serious consequences. This 
is exemplified by the function of NETs during thrombo-
sis: they are essential for timely coagulation in case of vas-
cular trauma, and they are presumably quickly broken 
down by serum DNase 1 after the wound is sealed. When 
DNase 1 is not fully active, NET remnants expose auto-
antigens and may foster the progression to autoimmune 
disorders like systemic lupus erythematosus, potentially 
leading to lupus nephritis. When both DNA-degrading 
serum enzymes, i.e., DNase 1 and DNase 1-like protein 3, 
are missing, NET formation due to sterile neutrophilia or 
sepsis has abysmal consequences leading to generalized 
vessel obstruction with organ failure and rapid death. 
For a number of other diseases the role of NETs still 
needs to be defined. Many of these studies are limited 
since they show the presence of neutrophils and extracel-
lular DNA but fail to unequivocally detect NETs. As long 
as there are no antibodies against epitopes available that 
are exclusively present in NETs, a complex of DNA/chro-
matin and granular/cytoplasmic neutrophil components 
needs to be demonstrated, e.g., by means of immunofluo-
rescence (Fig. 2) or sandwich ELISA.
With the evolving concept of aberrant NET formation 
or their insufficient removal as a pathomechanism, it be-
comes even more important to better understand the di-
verse signaling pathways that finally lead to NETosis and 
to develop tools to intervene. Recombinant DNase 1 has 
successfully been administered to liquefy CF sputum, and 
NE inhibitors are used in COPD. Peptidylarginine deim-
inase 4 is overexpressed in a majority of human cancers, 
and inhibitors could improve the clinical outcome. A bet-
ter comprehension of the molecules involved in induc-
tion of NETs and the mechanisms that dismantle them 
will enable us to successfully modify the pathogenic po-
tential of NETs.
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